Narrative updates are currently in beta.

Back to narrative

Update shared on30 Jul 2025

Fair value Increased 7.40%
AnalystConsensusTarget's Fair Value
₹2,790.00
17.5% undervalued intrinsic discount
30 Jul
₹2,302.80
Loading
1Y
16.7%
7D
-2.3%

Despite a slowdown in consensus revenue growth forecasts and a notable increase in the future P/E multiple, analysts have raised the fair value estimate for MPS from ₹2,598 to ₹2,790.


What's in the News


  • Board meeting scheduled to approve and take on record Q1 FY26 unaudited financial results.
  • Final dividend of INR 50 per equity share recommended for FY25, in addition to an interim dividend of INR 33 per share.
  • Final dividend subject to shareholder approval at upcoming AGM; record date set as 13 August 2025.
  • Board approved and took on record audited financial results for Q4 and FY25 and recommended the final dividend, pending AGM approval.
  • Board approved the third grant of 58,900 employee stock options under the MPS Limited-Employee Stock Options Scheme 2023.

Valuation Changes


Summary of Valuation Changes for MPS

  • The Consensus Analyst Price Target has risen from ₹2598 to ₹2790.
  • The Consensus Revenue Growth forecasts for MPS has significantly fallen from 13.3% per annum to 11.1% per annum.
  • The Future P/E for MPS has significantly risen from 28.68x to 33.04x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.